Results 11 to 20 of about 13,105 (210)
, 2023 20.500.12530/87909New-generation imaging techniques and the increasing use of surgery in high-risk prostate cancer (PCa) allow us to detect many cases of nodal disease at initial diagnosis or after resection. The treatment of PCa with pathologic regional
Couñago, Felipe +10 more
core +1 more source
EO771, the first luminal B mammary cancer cell line from C57BL/6 mice
Cancer Cell International, 2020 Background Despite decades of therapeutic trials, effective diagnosis, many drugs available and numerous studies on breast cancer, it remains the deadliest cancer in women. In order to choose the most appropriate treatment and to understand the prognosis
Augustin Le Naour +11 more
doaj +1 more source
Antiestrogen therapy in recurrent ovarian cancer resulting in 28 months of stable disease: A case report and review of the literature [PDF]
Archive of Oncology, 2010 Hormonal therapy for adjuvant treatment of ovarian cancer may provide a low toxicity option in some patients with refractory disease. A 53 year-old patient with stage IIIC papillary serous ovarian cancer previously treated with multiple chemotherapy ...
Carter Jori +4 more
doaj +1 more source
Acta Médica Portuguesa, 2023 Introduction: Genomic assays are useful tools for tailoring adjuvant treatment in early breast cancer. We aimed to analyse the role of an institutional protocol of a genomic assay for chemotherapy de-escalation.
Diogo Martins-Branco +6 more
doaj +1 more source
Sexual quality of life in hormonotherapy for breast cancer patients
Brazilian Journal of Oncology, 2022 Objectives: To evaluate how hormonal therapy can impact breast cancer patients sexual quality of life and compare two widely used therapeutic agents: anastrozole and tamoxifen. Studies so far have evaluated the side effects of such therapy on
Pedro Paulo Perroni da Silva +7 more
doaj +1 more source
DRUGS PROVIDED TO BREAST CANCER PATIENTS WITHIN THE STATE PROGRAMS OF DRUG SUPPLY
Фармакоэкономика, 2016 The purpose of our research was to analyze the actual practice of medicine in patients with breast cancer in various regions of the Russian Federation in the framework of state programs of drug provision (procurement of essential drugs (EDPP) and of ...
M. V. Avxentyeva +6 more
doaj +1 more source
Cardiovascular Complications of Prostate Cancer Treatment
Frontiers in Pharmacology, 2020 Treatment of prostate cancer (PC) is a rapidly evolving field of pharmacology research. In recent years, numerous novel therapeutics that improve survival and ameliorate disease control have been approved.
Michał Wilk +2 more
doaj +1 more source
Case Reports in Oncology, 2022 Cyclin4/6-dependent kinase inhibitors (CDKIs) plus hormonotherapy currently represent the standard golden treatment for patients with estrogen receptor-positive (ER+), human epidermal growth factor receptor-2-negative (her-2−) advanced breast carcinoma ...
Vittorio Gebbia
doaj +1 more source
The role of estrogen receptors isoforms in breast cancer [PDF]
Archive of Oncology, 2006 Background: Estrogen and progesterone receptor (ER/PR) status is an accepted predictive marker in breast cancer. It is well known that breast tumors, which are ER(+) are more likely to respond to endocrine therapy. However, certain percentage of ER(+)/PR(
Mandušić Vesna +5 more
doaj +1 more source
Chlormadinone acetate is effective for hot flush during androgen deprivation therapy
Prostate International, 2013 To investigate the clinical efficacy of low-dose chlormadinone acetate (CMA) in prostate cancer patients who suffer from hot flushes that is a major side effect of androgen deprivation therapy.
Hidekazu Koike +5 more
doaj +1 more source